Skip to main content

Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar

Author(s): Rajeev, Malavika; Edosoa, Glenn; Hanitriniaina, Chantal; Andriamandimby, Soa Fy; Guis, Helene; et al

Download
To refer to this page use: http://arks.princeton.edu/ark:/88435/pr12x8z
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajeev, Malavika-
dc.contributor.authorEdosoa, Glenn-
dc.contributor.authorHanitriniaina, Chantal-
dc.contributor.authorAndriamandimby, Soa Fy-
dc.contributor.authorGuis, Helene-
dc.contributor.authorRamiandrasoa, Ravo-
dc.contributor.authorRatovoson, Rila-
dc.contributor.authorRandrianasolo, Laurence-
dc.contributor.authorAndriamananjara, Mamitiana-
dc.contributor.authorHeraud, Jean-Michel-
dc.contributor.authorBaril, Laurence-
dc.contributor.authorMetcalf, C. Jessica E.-
dc.contributor.authorHampson, Katie-
dc.date.accessioned2019-12-16T20:14:45Z-
dc.date.available2019-12-16T20:14:45Z-
dc.date.issued2018-11-30en_US
dc.identifier.citationRajeev, M, Edosoa, G, Hanitriniaina, C, Andriamandimby, SF, Guis, H, Ramiandrasoa, R, Ratovoson, R, Randrianasolo, L, Andriamananjara, M, Heraud, JM, Baril, L, Metcalf, CJE, Hampson, K. (2018). Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar. Vaccine, 10.1016/j.vaccine.2018.11.011en_US
dc.identifier.issn0264-410X-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/pr12x8z-
dc.description.abstract© 2018 The Authors. In Madagascar, dog-mediated rabies has been endemic for over a century, however there is little data on its incidence or impact. We collected data over a 16-month period on provisioning of post-exposure prophylaxis (PEP) at a focal clinic in the Moramanga District and determined the rabies status of biting animals using clinical and laboratory diagnosis. We find that animal rabies cases are widespread, and clinic-based triage and investigation are effective ways to increase detection of rabies exposures and to rule out non-cases. A high proportion of rabies-exposed persons from Moramanga sought (84%) and completed PEP (90% of those that initiated PEP), likely reflecting the access and free provisioning of PEP in the district. Current clinic vial sharing practices demonstrate the potential for intradermal administration of PEP in endemic African settings, reducing vaccine use by 50% in comparison to intramuscular administration. A high proportion of PEP demand was attributed to rabies cases, with approximately 20% of PEP administered to probable rabies exposures and an additional 20% to low-to-no risk contacts with confirmed/probable animal or human cases. Using a simplified decision tree and our data on rabies exposure status and health-seeking behavior, we estimated an annual incidence of 42–110 rabies exposures and 1–3 deaths per 100,000 persons annually. Extrapolating to Madagascar, we estimate an annual burden of 282–745 human rabies deaths with current PEP provisioning averting 1499–3958 deaths each year. Data from other clinics and districts are needed to improve these estimates, particularly given that PEP availability is currently limited to only 31 clinics in the country. A combined strategy of mass dog vaccination, enhanced surveillance, and expanded access to PEP along with more judicious guidelines for administration could effectively reduce and eventually eliminate the burden of rabies in Madagascar.en_US
dc.format.extent1 - 10en_US
dc.language.isoenen_US
dc.relation.ispartofVaccineen_US
dc.rightsAuthor's manuscripten_US
dc.titleHealthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascaren_US
dc.typeJournal Articleen_US
dc.identifier.doidoi:10.1016/j.vaccine.2018.11.011-
dc.identifier.eissn1873-2518-
pu.type.symplectichttp://www.symplectic.co.uk/publications/atom-terms/1.0/journal-articleen_US

Files in This Item:
File Description SizeFormat 
healthcare utilization.pdf697.93 kBAdobe PDFView/Download


Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.